Oxford-AstraZeneca Vaccine Put On Hold After Volunteer Develops Unexplained Illness
London: In a bit of a setback, a phase 3 clinical study of the COVID-19 vaccine developed by the University of Oxford and British pharmaceutical company AstraZeneca has placed a 'routine…